ALPHA-SYNUCLEIN KINASE

The invention provides agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient. Preferred agents include inhibitors of PLK2 and GRK6 kinases. L'invention concerne des agents et des méthodes de traitement de maladies associées aux maladies...

Full description

Saved in:
Bibliographic Details
Main Authors BANDUCCI, KELLY, CHEREAU, DAVID, FRIGON, NORMAND, L., JR, GOLDSTEIN, JASON, BASI, GURIQBAL, S, CHILCOTE, TAMIE, J, ANDERSON, JOHN, P, GRIWOLD-PRENNER, IRENE
Format Patent
LanguageEnglish
French
Published 09.08.2007
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
COMPOSITIONS THEREOF
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
CULTURE MEDIA
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The invention provides agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient. Preferred agents include inhibitors of PLK2 and GRK6 kinases. L'invention concerne des agents et des méthodes de traitement de maladies associées aux maladies à corps de Lewy (LBD) dans le cerveau d'un patient. Les agents préférs comprennent des inhibiteurs des PLK2 et GRK6 kinases.
Bibliography:Application Number: WO2007US02685